Subscribe

Don't miss any update with Africazine.

― Advertisement ―

spot_img

Breakthrough Trial: Two-Dose Pneumococcal Vaccine Proves Highly Effective in Gambia!

Discover the results of a randomized non-inferiority trial conducted in The Gambia, demonstrating that a two-dose primary schedule of the pneumococcal conjugate vaccine (PCV13) offers comparable clinical protection to traditional vaccination methods. Source: Africazine.
HomeNewsIvory Coast-based eyecare startup Lapaire secures $3m to expand across Africa

Ivory Coast-based eyecare startup Lapaire secures $3m to expand across Africa

Ivory Coast-based eyecare startup Lapaire has secures US$3 million in equity funding to fuel its growth and expand across Africa.

Founded in 2018, Lapaire offers a trusted and accessible eyecare experience, leveraging a one-stop-shop customer-centric approach to provide stylish quality eyeglasses at fair prices. 

So far, the startup has tested the eyesight of more than 300,000 people and improved the lives of 180,000 of them. Lapaire fully operates 58 branches in six countries in Africa – Ivory Coast, Togo, Benin, Mali, Burkina Faso and Uganda. 

Lapaire’s US$3 million funding round was led by Investisseurs & Partenaires (I&P), with participation from AAIC, FINCA Ventures and Beyond Capital. The funds raised will be used to expand Lapaire’s footprint in current and new African markets, as well as to keep optimising its operations. It wants to open 300 new eye care centres across Africa. 

“Over the last few years, we worked hard to build a highly scalable model, and we are now in the best position to accelerate our growth to positively impact the life of one million people across the continent by 2026,” said Jerome Lapaire, founder and CEO of Lapaire.